Capital Allowances. 8.5.1 The book value of each of the assets of the Company in or adopted for the purposes of the Accounts on which capital allowances have been calculated separately does not exceed the written down value of such asset for the purposes of the CAA and the aggregate book value of plant and machinery for which capital allowances have been claimed under Part II of that Act does not exceed the written down value of the qualifying expenditure under the CAA. 8.5.2 The Company has not been a party to or involved in any transaction whereby a balancing allowance would be denied or reduced by virtue of section 5 CAA. 8.5.3 No allowances have been claimed by the Company which are liable to be reduced or withdrawn by virtue of sections 1(6), 42 or 47 CAA. 8.5.4 No capital expenditure has been incurred since the Balance Sheet Date which is subject to the provisions of section 75 CAA.
Appears in 1 contract
Sources: Agreement for the Sale and Purchase of Shares (Pharmacopeia Inc)
Capital Allowances. 8.5.1 The book value of each of the assets of the Company in or adopted for the purposes of the Accounts on which capital allowances have been are calculated separately does not exceed the written down value of such asset for the purposes of the CAA and the aggregate book value of plant and machinery for which capital allowances have been claimed under Part II of that Act does not exceed the written down value of the qualifying expenditure under the CAAthat Act.
8.5.2 The Company has not been a party to or involved in any transaction whereby a balancing allowance would be denied or reduced by virtue of section 5 CAA.
8.5.3 No allowances have been claimed by the Company which are liable to be reduced or withdrawn by virtue of sections 1(6), 42 or 47 CAA.
8.5.4 No capital expenditure has been incurred since the Balance Sheet Date which is subject to the provisions of section 75 CAA.
Appears in 1 contract
Capital Allowances. 8.5.1 8.5.1. The book value of each of the assets of the Company in or adopted for the purposes of the Accounts on which capital allowances have been are calculated separately does not exceed the written down value of such asset for the purposes of the CAA and the aggregate book value of plant and machinery for which capital allowances have been claimed under Part II of that Act does not exceed the written down value of the qualifying expenditure under the CAAthat Act.
8.5.2 8.5.2. The Company has not been a party to or involved in any transaction whereby a balancing allowance would be denied or reduced by virtue of section 5 CAA.
8.5.3 8.5.3. No allowances have been claimed by the Company which are liable to be reduced or withdrawn by virtue of sections 1(6), 42 or 47 CAA.
8.5.4 8.5.4. No capital expenditure has been incurred since the Balance Sheet Date which is subject to the provisions of section 75 CAA.
Appears in 1 contract
Sources: Agreement for the Sale and Purchase of Shares (Pharmacopeia Inc)
Capital Allowances. 8.5.1 6.5.1. The book value of each of the assets of the Company in or adopted for the purposes of the Accounts on which capital allowances have been are calculated separately does not exceed the written down value of such asset for the purposes of the CAA and the aggregate book value of plant and machinery for which capital allowances have been claimed under Part II of that Act does not exceed the written down value of the qualifying expenditure under the CAAthat Act.
8.5.2 6.5.2. The Company has not been a party to or involved in any transaction whereby a balancing allowance would be denied or reduced by virtue of section Section 5 CAA.
8.5.3 6.5.3. No allowances have been claimed by the Company which are liable to be reduced or withdrawn by virtue of sections Sections 1(6), 42 or 47 CAA.
8.5.4 6.5.4. No capital expenditure has been incurred since the Balance Sheet Date which is subject to the provisions of section Section 75 CAA.
Appears in 1 contract
Sources: Share Sale Agreement (Intertan Inc)